🔎 Trials Near Me

홈 › 흑색종 › 테네시

테네시의 흑색종 임상 시험

흑색종 관련 연구 42개가 테네시 내 여러 지역에서 참여자를 모집하고 있습니다.

테네시의 도시

공식 연구 텍스트(영어)

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

  • Tennessee Oncology, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06270706

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

  • Tennessee Oncology - Chattanooga, Chattanooga
  • University of Tennessee Medical Center, Knoxville
  • Sarah Cannon Research Institute (SCRI) Oncology Partners, Nashville
  • 외 1개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT06246916

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

  • University of Tennessee Health Science Center, Knoxville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT04198766

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

  • Sarah Cannon Research Institute- Pharmacy, Nashville
  • SCRI Oncology Partners, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07519655

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

  • Tennessee Oncology, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06150664

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital for Women, Memphis
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06418204

SI-B036-ST-101 in Advanced/Metastatic Solid Tumors

  • Sarah Cannon Research Institute - Oncology Partners, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07857616

A Study of BI 3810944 in Patients With Advanced Cancer

  • Tennessee Oncology, PLLC - Elliston Place Plaza DDU, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT07224425

Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab

  • Sarah Cannon Research Institute, Nashville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT07751042

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  • Erlanger Health, Inc, Chattanooga
  • The West Clinic, Germantown
  • SCRI Oncology Partners, Nashville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT06330064

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • SCRI Oncology Partners, Nashville
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT06172478

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

  • Sarah Cannon Research Institute Oncology Partners, Nashville
  • Vanderbilt-Ingram Cancer Institute, Nashville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT07287917

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

  • Research Site 136, Nashville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT05914116

DESTINY-PANTUMOUR04

  • Research Site, Nashville
피험자 모집 중관찰 연구
18세 ~ 130세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07124000

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

  • Vanderbilt University Medical Center, Nashville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06047379

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

  • Baptist Cancer Center, Bartlett
  • SCRI Oncology Partners, Nashville
피험자 모집 중3상
18세 ~ 70세 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT05727904

A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information

  • East Tennessee Childrens Hospital, Knoxville
  • Saint Jude Children's Research Hospital, Memphis
피험자 모집 중2상
25세 이하 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT07621614

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

  • Vanderbilt University/Ingram Cancer Center, Nashville
피험자 모집 중3상
75세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT07068074

R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors

  • Sarah Cannon Research Institute, Nashville
피험자 모집 중1상
18세 ~ 80세 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT06398418

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

  • Sarah Cannon Research Institute, Nashville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT05267626

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

  • Sarah Cannon Research Institute-Tennessee Oncology, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT04913285

Project: Every Child for Younger Patients With Cancer

  • T C Thompson Children's Hospital, Chattanooga
  • East Tennessee Childrens Hospital, Knoxville
  • Saint Jude Children's Research Hospital, Memphis
  • 외 2개
피험자 모집 중관찰 연구
25세 이하 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT02402244

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Saint Jude Children's Research Hospital, Memphis
피험자 모집 중1/2상
12 Months – 30 Years · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT04851119

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

  • Vanderbilt University Medical Center, Nashville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT04895709

Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors

  • Tennessee Oncology, PLLC, Nashville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 14. 업데이트됨 · NCT06425926

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

  • Sarah Cannon Research Institute Oncology Partners (SCRI-Nashville), Nashville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT05592626

Familial Investigations of Childhood Cancer Predisposition

  • St. Jude Children's Research Hospital, Memphis
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2026. 6. 17. 업데이트됨 · NCT03050268

A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel

  • Sarah Cannon Research Institute, Nashville
피험자 모집 중1/2상
18세 ~ 70세 · 모든 성별 · 2026. 6. 15. 업데이트됨 · NCT06940739

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

  • The Sarah Cannon Research Institute/Tennessee Oncology, Nashville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 6. 8. 업데이트됨 · NCT03947385

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

  • St. Jude Children's Research Hospital, Memphis
피험자 모집 중1상
21세 이하 · 모든 성별 · 2026. 5. 19. 업데이트됨 · NCT04897321

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

  • Tennessee Oncology, Chattanooga
  • Sarah Cannon Research Institute, Nashville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 5. 15. 업데이트됨 · NCT05379985

Neoadjuvant Darovasertib in Primary Uveal Melanoma

  • SCRI Oncology Partners, Nashville
  • Vanderbilt Eye Institute, Nashville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 5. 6. 업데이트됨 · NCT07015190

Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy

  • Vanderbilt-Ingram Cancer Center, Nashville
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 5. 6. 업데이트됨 · NCT07555210

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

  • SCRI Oncology Partners, Nashville
  • Vanderbilt-Ingram Cancer Center, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 4. 20. 업데이트됨 · NCT06326411

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

  • The West Clinic, PLLC dba West Cancer Center, Germantown
  • University of Tennessee Medical Center, Knoxville
  • Sarah Cannon Research Institute, Nashville
  • 외 1개
피험자 모집 중2/3상
전 연령 · 모든 성별 · 2026. 4. 2. 업데이트됨 · NCT06581406

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

  • University of Tennessee Medical Center, Knoxville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 2. 25. 업데이트됨 · NCT05549297

Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma

  • Vanderbilt-Ingram Cancer Center, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 2. 13. 업데이트됨 · NCT04903119

Molecular Analysis of Childhood and Adolescent Melanocytic Lesions

  • St. Jude Children's Research Hospital, Memphis
피험자 모집 중관찰 연구
18세 이하 · 모든 성별 · 2025. 11. 10. 업데이트됨 · NCT02775643

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Memphis
  • Massive Bio SYNERGY-AI site, Nashville
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774

Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment

  • Vanderbitl-Ingram Cancer Center, Nashville
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2025. 9. 19. 업데이트됨 · NCT01205815

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.